van Slooten GW - Search Results

1

Value of laboratory tests in monitoring acute regional toxicity after isolated limb perfusion.

Vrouenraets BC, Kroon BB, Klaase JM, Bonfrer JM, Nieweg OE, van Slooten GW, van Dongen JA. Vrouenraets BC, et al. Among authors: van slooten gw. Ann Surg Oncol. 1997 Jan;4(1):88-94. doi: 10.1007/BF02316815. Ann Surg Oncol. 1997. PMID: 8985522

2

Isolated limb perfusion with tumor necrosis factor-alpha and melphalan for patients with unresectable soft tissue sarcoma of the extremities.

Noorda EM, Vrouenraets BC, Nieweg OE, van Coevorden F, van Slooten GW, Kroon BB. Noorda EM, et al. Among authors: van slooten gw. Cancer. 2003 Oct 1;98(7):1483-90. doi: 10.1002/cncr.11648. Cancer. 2003. PMID: 14508836 Free article.

3

Isolated limb perfusion for melanoma.

Kroon BB, Noorda EM, Vrouenraets BC, van Slooten GW, Nieweg OE. Kroon BB, et al. Among authors: van slooten gw. Surg Oncol Clin N Am. 2008 Oct;17(4):785-94, viii-ix. doi: 10.1016/j.soc.2008.04.005. Surg Oncol Clin N Am. 2008. PMID: 18722918 Review.

4

Comparison between the use of whole blood versus a diluted perfusate in regional isolated perfusion by continuous monitoring of transcutaneous oxygen tension: a pilot study.

Klaase JM, Kroon BB, van Slooten GW, van Dongen JA, van de Merwe SA, van der Zee J. Klaase JM, et al. Among authors: van der zee j, van dongen ja, van slooten gw, van de merwe sa. J Invest Surg. 1994 May-Jun;7(3):249-58. doi: 10.3109/08941939409018290. J Invest Surg. 1994. PMID: 7918247

5

Melphalan tissue concentrations in patients treated with regional isolated perfusion for melanoma of the lower limb.

Klaase JM, Kroon BB, Beijnen JH, van Slooten GW, van Dongen JA. Klaase JM, et al. Among authors: van slooten gw. Br J Cancer. 1994 Jul;70(1):151-3. doi: 10.1038/bjc.1994.266. Br J Cancer. 1994. PMID: 8018528 Free PMC article.

6

Severe acute regional toxicity after normothermic or 'mild' hyperthermic isolated limb perfusion with melphalan for melanoma.

Vrouenraets BC, Kroon BB, Klaase JM, Nieweg OE, van Slooten GW, van Dongen JA. Vrouenraets BC, et al. Among authors: van slooten gw. Melanoma Res. 1995 Dec;5(6):425-31. doi: 10.1097/00008390-199512000-00006. Melanoma Res. 1995. PMID: 8589617

7

Physiological implications of hyperbaric oxygen tensions in isolated limb perfusion using melphalan: a pilot study.

Vrouenraets BC, Kroon BB, van de Merwe SA, Klaase JM, Broekmeyer-Reurink MP, van Slooten GW, Nieweg OE, van der Zee J, van Dongen JA. Vrouenraets BC, et al. Among authors: van slooten gw. Eur Surg Res. 1996;28(3):235-44. doi: 10.1159/000129462. Eur Surg Res. 1996. PMID: 8738534

8

Long-term functional morbidity after mild hyperthermic isolated limb perfusion with melphalan.

Vrouenraets BC, in't Veld GJ, Nieweg OE, van Slooten GW, van Dongen JA, Kroon BB. Vrouenraets BC, et al. Among authors: van slooten gw. Eur J Surg Oncol. 1999 Oct;25(5):503-8. doi: 10.1053/ejso.1999.0686. Eur J Surg Oncol. 1999. PMID: 10529261 Clinical Trial.

9

8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.

Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H. Verwaal VJ, et al. Ann Surg Oncol. 2008 Sep;15(9):2426-32. doi: 10.1245/s10434-008-9966-2. Epub 2008 Jun 3. Ann Surg Oncol. 2008. PMID: 18521686 Clinical Trial.

10

Long-term survival of peritoneal carcinomatosis of colorectal origin.

Verwaal VJ, van Ruth S, Witkamp A, Boot H, van Slooten G, Zoetmulder FA. Verwaal VJ, et al. Ann Surg Oncol. 2005 Jan;12(1):65-71. doi: 10.1007/s10434-004-1167-z. Epub 2004 Dec 27. Ann Surg Oncol. 2005. PMID: 15827780 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page